ArticleBrain & spine2026
EQ-5D vs SF-6D: Discrepancies in measuring quality of life for patients with vertebral compression fractures.
Article in Brain & spine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: EuroQoL-5D (EQ-5D) and SF-6D are both designed to measure health states or utility but differ in questionnaire structure and scoring algorithm. This yields divergent results in several populations. The magnitude of this discrepancy in patients with osteoporotic vertebral compression fractures (OVCF) is unknown. Research question: To compare EQ-5D and SF-6D in determining health states and utility in patients with OVCF. Materials and methods: Registry EQ-5D and SF-6D from patients treated for OVCF with vertebroplasty at a single center were obtained for a preoperative cross-sectional analysis. Response distributions were evaluated for boundary effects. Discrepancies between utility scores were assessed by Wilcoxon signed rank tests, intraclass correlation coefficients and Bland-Altman plots. Results: The analysis included 736 patients. The most frequent response was the floor level in a single EQ-5D dimension and in half of SF-6D dimensions. SF-6D utility median was 0.50 (range 0.30 to 0.91) and EQ-5D utility scores were bimodal with median 0.16 (range -0.594 to 1). Median difference (SF - EQ) was 0.34 (range -0.51 to 1.08). Inter-rater agreement was poor: ICC = 0.158 (CI -0.019; 0.314). Discussion and conclusion: EQ-5D and SF-6D are not interchangeable for patients with OVCF undergoing vertebroplasty. Median differences are large, and SF-6D produces systematically higher utility scores than EQ-5D in patients with poor health while the reverse is true for good health. Differing scoring algorithms and more floor effects in SF-6D than EQ-5D may contribute to utility discrepancy.Researchers are urged to be mindful of this discrepancy when interpreting health states and utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.